Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines

Citations Over TimeTop 10% of 2016 papers

Abstract

Background Central line associated bloodstream infections (CLABSIs) are a significant cause of morbidity and mortality in pediatric hematology/oncology (PHO) patients. Understanding the differences in CLABSI rates by central line (CL) type is important to inform clinical decisions. Procedure CLABSI, using similar definitions, noted with three commonly used CL types (totally implanted catheter [port], tunneled externalized catheter [TEC], peripherally inserted central catheter [PICC]) and CL‐specific line days were prospectively tracked across 15 US PHO centers from May 2012 until April 2015 and CLABSI rates (CLABSI per 1,000 CL‐specific line days) were calculated. Host and organism characterstics associated with the CLABSI events were analyzed. Results Over the course of 2.8 million line days, 1,113 CLABSI events (397 in inpatients and 716 in ambulatory patients) were noted. The inpatient CLABSI rate was higher than the ambulatory CLABSI rate for each of the CL types: 1.48 versus 0.16 for ports, 3.51 versus 1.38 for TECs, and 3.07 versus 1.16 for PICCs, respectively. TECs and PICCs were associated with higher CLABSI rates than ports, inpatient and ambulatory. Conclusions We found that CLABSI rates were significantly higher for inpatients compared to ambulatory PHO patients for all CL types. Among ambulatory patients, TECs had the highest CLABSI rate and ports the lowest. Among inpatients, TECs and PICCs had higher CLABSI rates than ports but were not statistically different from one another. Cognizant that host and underlying disease attributes may contribute to these differences, these results can still inform CL choice in clinical practice.

Related Papers

• → Peripherally Inserted Central Catheter Dwell Time as a Risk Factor of Central Line-Associated Bloodstream Infection in Neonates(2022)2 cited
• → Maintenance Related Interventions Successfully Reduce Central Line Associated Bloodstream Infections(2013)
• → Engagement of Frontline, Implementation of a Novel Needleless Connector Results in Dramatic Decrease in Central Line Associated Blood Stream Infections. Zero is Achievable!(2018)
• → Peripherally Inserted Central Venous Catheter (PICC) Insertion Site and Risk of Central Line Associated Blood Stream Infection (CLA-BSI) in Neonates(2013)
• → Pre-emptive replacement of peripherally inserted central catheters (PICCs) to prevent a ‘possible’ central line-associated bloodstream infection (CLABSI) in patients with haematological malignancies(2016)